Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])

Steven N. Singh; Bramah N. Singh; Domenic J. Reda; Carol L. Fye; Michael D. Ezekowitz; Ross D. Fletcher; Satish C. Sharma; J. Edwin Atwood; Alan K. Jacobson; H. Daniel Lewis; Eliott M. Antman; Rodney H. Falk; Becky Lopez; X. Charlene Tang

doi:10.1016/S0002-9149(03)00671-4

Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])

Steven N. Singh, Bramah N. Singh, Domenic J. Reda, Carol L. Fye, Michael D. Ezekowitz, Ross D. Fletcher, Satish C. Sharma, J. Edwin Atwood, Alan K. Jacobson, H. Daniel Lewis, Eliott M. Antman, Rodney H. Falk, Becky Lopez, X. Charlene Tang

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	468-472
Number of pages	5
Journal	American Journal of Cardiology
Volume	92
Issue number	4
DOIs	https://doi.org/10.1016/S0002-9149(03)00671-4
State	Published - Aug 15 2003

ASJC Scopus Subject Areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/S0002-9149(03)00671-4

OpenUrl availability

Full text

Cite this

Singh, S. N., Singh, B. N., Reda, D. J., Fye, C. L., Ezekowitz, M. D., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., Lewis, H. D., Antman, E. M., Falk, R. H., Lopez, B., & Tang, X. C. (2003). Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]). American Journal of Cardiology, 92(4), 468-472. https://doi.org/10.1016/S0002-9149(03)00671-4

Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]). / Singh, Steven N.; Singh, Bramah N.; Reda, Domenic J. et al.
In: American Journal of Cardiology, Vol. 92, No. 4, 15.08.2003, p. 468-472.

Research output: Contribution to journal › Article › peer-review

Singh, SN, Singh, BN, Reda, DJ, Fye, CL, Ezekowitz, MD, Fletcher, RD, Sharma, SC, Atwood, JE, Jacobson, AK, Lewis, HD, Antman, EM, Falk, RH, Lopez, B & Tang, XC 2003, 'Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])', American Journal of Cardiology, vol. 92, no. 4, pp. 468-472. https://doi.org/10.1016/S0002-9149(03)00671-4

@article{9a1bcf022ca34932b09bb23f3cbe4b7f,

title = "Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])",

author = "Singh, {Steven N.} and Singh, {Bramah N.} and Reda, {Domenic J.} and Fye, {Carol L.} and Ezekowitz, {Michael D.} and Fletcher, {Ross D.} and Sharma, {Satish C.} and Atwood, {J. Edwin} and Jacobson, {Alan K.} and Lewis, {H. Daniel} and Antman, {Eliott M.} and Falk, {Rodney H.} and Becky Lopez and Tang, {X. Charlene}",

note = "Funding Information: This study was supported by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development. The blinded drug preparations and their respective placebos were provided by Wyeth Pharmaceuticals (amiodarone), Philadelpha, Pennsylvania, and Berlex Pharmaceuticals (sotalol), Atlanta, Georgia. Both companies also provided additional funds in support of the study in general. ",

year = "2003",

month = aug,

day = "15",

doi = "10.1016/S0002-9149(03)00671-4",

language = "English",

volume = "92",

pages = "468--472",

journal = "American Journal of Cardiology",

issn = "0002-9149",

number = "4",

}

TY - JOUR

T1 - Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])

AU - Singh, Steven N.

AU - Singh, Bramah N.

AU - Reda, Domenic J.

AU - Fye, Carol L.

AU - Ezekowitz, Michael D.

AU - Fletcher, Ross D.

AU - Sharma, Satish C.

AU - Atwood, J. Edwin

AU - Jacobson, Alan K.

AU - Lewis, H. Daniel

AU - Antman, Eliott M.

AU - Falk, Rodney H.

AU - Lopez, Becky

AU - Tang, X. Charlene

N1 - Funding Information: This study was supported by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development. The blinded drug preparations and their respective placebos were provided by Wyeth Pharmaceuticals (amiodarone), Philadelpha, Pennsylvania, and Berlex Pharmaceuticals (sotalol), Atlanta, Georgia. Both companies also provided additional funds in support of the study in general.

PY - 2003/8/15

Y1 - 2003/8/15

UR - http://www.scopus.com/inward/record.url?scp=0041562561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041562561&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(03)00671-4

DO - 10.1016/S0002-9149(03)00671-4

M3 - Article

C2 - 12914883

AN - SCOPUS:0041562561

SN - 0002-9149

VL - 92

SP - 468

EP - 472

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 4

ER -

Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this